- Home
- MOLN vs CFBK Comparison
MOLN vs CFBK Comparison
Compare MOLN & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- CFBK
- Stock Information
- Founded
- MOLN 2004
- CFBK 1892
- Country
- MOLN Switzerland
- CFBK United States
- Employees
- MOLN N/A
- CFBK N/A
- Industry
- MOLN
- CFBK Major Banks
- Sector
- MOLN
- CFBK Finance
- Exchange
- MOLN Nasdaq
- CFBK Nasdaq
- Market Cap
- MOLN 142.6M
- CFBK 159.5M
- IPO Year
- MOLN 2021
- CFBK 1998
- Fundamental
- Price
- MOLN $3.75
- CFBK $25.11
- Analyst Decision
- MOLN Hold
- CFBK Buy
- Analyst Count
- MOLN 1
- CFBK 1
- Target Price
- MOLN $4.00
- CFBK $29.00
- AVG Volume (30 Days)
- MOLN 5.2K
- CFBK 33.2K
- Earning Date
- MOLN 11-05-2025
- CFBK 10-29-2025
- Dividend Yield
- MOLN N/A
- CFBK 1.27%
- EPS Growth
- MOLN N/A
- CFBK 36.66
- EPS
- MOLN N/A
- CFBK 2.77
- Revenue
- MOLN $856,302.00
- CFBK $52,793,000.00
- Revenue This Year
- MOLN N/A
- CFBK $39.98
- Revenue Next Year
- MOLN $1,000.00
- CFBK $10.47
- P/E Ratio
- MOLN N/A
- CFBK $9.12
- Revenue Growth
- MOLN N/A
- CFBK 20.91
- 52 Week Low
- MOLN $3.36
- CFBK $19.23
- 52 Week High
- MOLN $7.60
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- MOLN 51.77
- CFBK 60.39
- Support Level
- MOLN $3.69
- CFBK $24.80
- Resistance Level
- MOLN $3.85
- CFBK $25.97
- Average True Range (ATR)
- MOLN 0.15
- CFBK 0.49
- MACD
- MOLN 0.01
- CFBK 0.03
- Stochastic Oscillator
- MOLN 37.27
- CFBK 49.11
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.